Penile Cancer Clinical Trial
— BRUCYOfficial title:
Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions
In an attempt to reduce patient flow into the hospital we are going to assess the use of penile cytological brushings and dermoscopy in diagnosing cancer or non-cancer conditions of the penis.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | January 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. All patients requiring either diagnostic biopsy or WLE (wide local excision) of a lesion of the penis 2. Age > 18 years 3. Written informed consent provided by the patient 4. Subject has been scheduled for surgical intervention, with a biopsy procedure being a part of the surgical plan Exclusion Criteria: 1. Subject is unfit for surgery upon surgeon's assessment. 2. Unable to provide consent 3. Those with terminal disease 4. Those with palpable lymph nodes 5. Other coincident cancers 6. Previous radiotherapy treatment to the penis, bladder, prostate, anus 7. Subject is deprived of liberty or under guardianship 8. Subject is not able to follow and understand the procedures of the study due to mental state or other reasons |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The Christie NHS Foundation Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Does cytology results compare equally with standard histological biopsy for detecting cancer | Concordance of cytology vs Histopathology i.e. is the cytology assessment equal to histopathology results when detecting cancer | Through study completion, expected to be 12 months | |
Primary | Does the use of dermoscopy photography enable us to identify abnormal cellular changes that compare equally to the results obtained with standard histological biopsy. | Concordance of dermoscopy vs Histopathology in detecting cancer i.e. does the use of dermoscopy photographs enable us to identify cancer and compare equally to results obtained by histopathology | Through study completion, expected to be 12 months | |
Secondary | Patient satisfaction with cytological brushing diagnostic method being tested | All patients on study will be asked their views on the cytology brushing technique being used to gauge their satisfaction and experience of the new diagnostic method being tested | Through study completion, expected to be 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03686332 -
PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
|
Phase 2 | |
Completed |
NCT05518201 -
Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
|
Phase 1 | |
Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04357873 -
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
|
Phase 2 | |
Terminated |
NCT00058448 -
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
|
Phase 2 | |
Recruiting |
NCT02817958 -
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
|
Phase 2 | |
Completed |
NCT02280811 -
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
|
Phase 2 | |
Recruiting |
NCT02994758 -
Development of Diagnostics and Treatment of Urological Cancers
|
N/A | |
Completed |
NCT00019110 -
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
|
Phase 1 | |
Completed |
NCT04574427 -
INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue
|
||
Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
Recruiting |
NCT05946993 -
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Recruiting |
NCT05686226 -
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
|
Phase 2 | |
Completed |
NCT05376202 -
Image Guided Penile Cancer Surgery
|
Phase 1 | |
Recruiting |
NCT05264337 -
Lymphedema After Urologic Surgery
|
||
Recruiting |
NCT03774901 -
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma
|
Phase 2 | |
Completed |
NCT01209325 -
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
|
Phase 2 | |
Recruiting |
NCT05592639 -
VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer
|
N/A | |
Completed |
NCT00066391 -
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
|
Phase 2 |